z-logo
Premium
Bimodal regulatory effect of melittin and phospholipase A 2 ‐activating protein on human type II secretory phospholipase A 2
Author(s) -
Koumanov K.,
Momchilova A.,
Wolf C.
Publication year - 2003
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1016/s1065-6995(03)00176-8
Subject(s) - melittin , phospholipase a2 , phospholipid , membrane , biochemistry , peptide , substrate (aquarium) , phospholipase , liposome , chemistry , enzyme , vesicle , phospholipase a , biophysics , biology , ecology
Melittin and phospholipase A 2 ‐activating protein (PLAP) are known as efficient activators of secretory phospholipase A 2 (sPLA 2 ) types I, II, and III when phospholipid liposomes are used as substrate. The present study demonstrates that both peptides can either inhibit or activate sPLA 2 depending on the peptide/phospholipid ratio when erythrocyte membranes serve as a biologically relevant substrate. Low concentrations of melittin and PLAP were observed to inhibit sPLA 2 –triggered release of fatty acids from erythrocyte membranes. The inhibition was reversed at melittin concentrations above 1 μM. PLAP‐induced inhibition of sPLA 2 persisted steadily throughout the used concentration range (0–150 nM). The two peptides induced a dose‐dependent activation of sPLA 2 at low concentrations, followed by inhibition when model membranes were used as substrate. This opposite modulatory effect on biological membranes and model membranes is discussed with respect to different mechanisms the interaction of the regulatory peptides with the enzyme molecules and the substrate vesicles.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here